Valuation: PharmaEssentia Corporation

Market Cap 484B 15.01B 13.13B 12.13B 11.16B 21.08B 1,447B 21.46B 145B 56.85B 708B 56.34B 55.11B 2,438B P/E 2026 *
45.1x
P/E 2027 * 32.8x
Enterprise Value 458B 14.18B 12.41B 11.47B 10.55B 19.93B 1,368B 20.28B 137B 53.74B 669B 53.26B 52.1B 2,304B EV / Sales 2026 *
18.3x
EV / Sales 2027 * 13x
Free-Float
75.37%
Yield 2026 *
0.08%
Yield 2027 * 0.12%
1 day-1.67%
1 week-8.56%
Current month-2.73%
1 month+22.96%
3 months+99.60%
6 months+125.89%
Current year+177.32%
1 week 1,165
Extreme 1165
1,365
1 month 915.01
Extreme 915.0097
1,415.34
Current year 423.7
Extreme 423.6991
1,415.34
1 year 395.61
Extreme 395.6133
1,415.34
3 years 222.58
Extreme 222.5833
1,415.34
5 years 56.05
Extreme 56.052
1,415.34
10 years 43.54
Extreme 43.5418
1,415.34
Manager TitleAgeSince
Chief Executive Officer - 01/01/2003
Director of Finance/CFO - 14/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 01/09/2003
Director/Board Member - -
Director/Board Member - 30/06/2009
Change 5-day change 1-year change 3-year change Capi.($)
-1.67%-8.56%+163.95%+284.69% 15.2B
+0.21%-1.34%+53.17%+60.65% 53.83B
+5.37%+0.75%+50.39%+83.03% 52.1B
-1.20%-7.43%+4.35%+406.96% 23.48B
+0.74%+0.73%-16.23%-15.55% 23.13B
+3.46%+0.79%+34.01%-4.47% 19.36B
-1.18%-1.15%+30.12%-32.02% 17.56B
+3.62%-2.42%+29.70%+663.64% 14.83B
-0.70%-1.72%+24.87%+184.19% 14.06B
-3.21%-0.19%+60.32%+147.14% 12.76B
Average +0.54%-1.88%+43.46%+177.82% 24.63B
Weighted average by Cap. +1.23%-2.06%+42.44%+141.17%

Financials

2026 *2027 *
Net sales 25.07B 777M 680M 628M 577M 1.09B 74.89B 1.11B 7.51B 2.94B 36.62B 2.92B 2.85B 126B 34.57B 1.07B 937M 866M 796M 1.5B 103B 1.53B 10.35B 4.06B 50.49B 4.02B 3.93B 174B
Net income 10.85B 336M 294M 272M 250M 472M 32.43B 481M 3.25B 1.27B 15.85B 1.26B 1.24B 54.63B 14.97B 464M 406M 375M 345M 652M 44.73B 663M 4.48B 1.76B 21.87B 1.74B 1.7B 75.35B
Net Debt -26.52B -822M -719M -664M -611M -1.15B -79.24B -1.17B -7.94B -3.11B -38.74B -3.09B -3.02B -133B -34.73B -1.08B -941M -870M -800M -1.51B -104B -1.54B -10.4B -4.08B -50.73B -4.04B -3.95B -175B
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
20/07/26 NT$1,175.00 -1.67% 2,926,691
17/07/26 NT$1,195.00 -5.16% 3,377,763
16/07/26 NT$1,260.00 -4.55% 4,420,281
15/07/26 NT$1,320.00 +10.00% 2,157,754
14/07/26 NT$1,200.00 -4.00% 4,037,292
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,175.00TWD
Average target price
1,073.31TWD
Spread / Average Target
-8.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock